Covaxin has the potential to develop antibodies on new Corona strain

The icmr, india's highest medical research institute, has done significant research on the new strain of corona found in Britain. consistent with this research, the bharat biotechs Covaxin has the potential to develop antibodies which will be effective on this new strain. Covaxin ( Vaccine ) is that the first indigenous corona vaccine and therefore the Bharat Biotech of Hyderabad has prepared it with the assistance of the National Institute of Virology (NIV) in Pune.

Earlier this year, ICMR announced earlier this year that niv successfully has successfully esolated and cultured The Stron by those that had come to India from Britain and had been hampered by this new strain.

The new strain, found in Britain, is 50 to 70 percent more contagious than the previous Corona virus. Some cases also showed that it had been more dangerous than the old virus. However, research remains on.

India Biotech had already expressed confidence that Covaccin would work against the new strain in Britain. the businesses , which have also created figers, moderna, oxford-astrazeneca, claimed that their vaccine was effective on new strain.